Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 64-68 , January 2010

Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes

Received 1 June 2009 ,Revised 16 October 2009 ,Accepted 22 October 2009.

References 

  1. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia. 2002;45:937–948
  2. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet. Med. 2008;25:501–504
  3. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 1991;8:217–222
  4. Muhlhauser I, Heinemann L, Fritsche E, von Lennep K, Berger M. Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care. 1991;14:745–749
  5. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703
  6. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–522
  7. Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care. 2007;30:1868–1870
  8. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 1993;42:1683–1689
  9. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  10. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28:2948–2961
  11. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 1993;10:231–237
  12. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM. 1995;88:439–445
  13. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–141
  14. Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet. Med. 1998;15:398–401
  15. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance and emotions. In:  Frier BM,  Fisher M editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley and Sons; 2007;p. 25–48
  16. Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–1517
  17. UK Hypoglycaemia Study Group . Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140–1147
  18. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, et al. for the DARTS/MEMO Collaboration Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 2005;22:749–755
  19. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 2004;20:479–486
  20. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In:  Frier BM,  Fisher BM editor. Hypoglycaemia in Clinical Diabetes. 2nd ed.. Chichester: John Wiley and Sons; 2007;p. 49–81
  21. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet. Med. 2003;20:1016–1021
  22. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Recall of severe hypoglycaemic episodes and course of hypoglycaemia awareness in insulin treated Type 2 diabetes in one year follow-up. Diabetologia. 2003;46(Suppl. 2):A304;(abstract)
  23. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia. 1993;36:771–777
  24. Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet. Med. 2006;23:750–756
  25. Geddes J, Frier BM. Severe hypoglycaemia in insulin-treated Type 2 diabetes. Diabet. Med. 2007;24:327;(letter)

☆ The present study was presented as a poster at the annual conference of the European Association for the Study of Diabetes in Rome in 2008. Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia in insulin-treated Type 2 diabetes and its effect on hypoglycaemia frequency. Diabetologia 2008;51(Suppl. 1):S274 [abstract].

☆☆ Research grants: Josefine Schopman was supported by a research grant from the Dutch Diabetes Foundation and Jacqueline Geddes by a research grant (CZB/4/423) from the Chief Scientist Office of the Department of Health of the Scottish Executive.

PII: S0168-8227(09)00461-6

doi: 10.1016/j.diabres.2009.10.013

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 64-68 , January 2010

Article Tools

* Image Usage & Resolution